NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 197 filers reported holding NEVRO CORP in Q3 2021. The put-call ratio across all filers is 2.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,020,536 | -40.9% | 209,185 | -21.8% | 0.02% | -38.5% |
| Q2 2023 | $6,803,434 | -33.2% | 267,641 | -5.0% | 0.04% | -37.1% |
| Q1 2023 | $10,189,781 | +12.6% | 281,875 | +23.3% | 0.06% | +1.6% |
| Q4 2022 | $9,050,184 | +107.5% | 228,540 | +144.2% | 0.06% | +79.4% |
| Q3 2022 | $4,361,000 | +3.2% | 93,583 | -2.9% | 0.03% | +3.0% |
| Q2 2022 | $4,226,000 | -40.2% | 96,414 | -1.4% | 0.03% | -31.2% |
| Q1 2022 | $7,071,000 | -33.7% | 97,762 | -25.7% | 0.05% | -32.4% |
| Q4 2021 | $10,672,000 | +652.6% | 131,640 | +980.4% | 0.07% | +610.0% |
| Q3 2021 | $1,418,000 | -31.4% | 12,184 | -2.2% | 0.01% | -28.6% |
| Q2 2021 | $2,066,000 | +18.9% | 12,460 | 0.0% | 0.01% | +7.7% |
| Q1 2021 | $1,738,000 | – | 12,460 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |